Roche Ventana pan-TRK Assay

Roche has launched its new Ventana pan-TRK Assay, which detects tropomyosin receptor kinase proteins in cancer. According to the firm, laboratories can now identify wild-type and chimeric fusion proteins by detecting the TRK C-terminal region. Researchers can run the assay on Roche's benchmark series of IHC/ISH automated staining instruments.